295 related articles for article (PubMed ID: 11083809)
41. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
[TBL] [Abstract][Full Text] [Related]
42. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells.
An H; Yu Y; Zhang M; Xu H; Qi R; Yan X; Liu S; Wang W; Guo Z; Guo J; Qin Z; Cao X
Immunology; 2002 May; 106(1):38-45. PubMed ID: 11972630
[TBL] [Abstract][Full Text] [Related]
43. Injury primes the innate immune system for enhanced Toll-like receptor reactivity.
Paterson HM; Murphy TJ; Purcell EJ; Shelley O; Kriynovich SJ; Lien E; Mannick JA; Lederer JA
J Immunol; 2003 Aug; 171(3):1473-83. PubMed ID: 12874240
[TBL] [Abstract][Full Text] [Related]
44. Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection.
Almeida PE; Roque NR; Magalhães KG; Mattos KA; Teixeira L; Maya-Monteiro C; Almeida CJ; Castro-Faria-Neto HC; Ryffel B; Quesniaux VF; Bozza PT
Biochim Biophys Acta; 2014 Jan; 1841(1):97-107. PubMed ID: 24120921
[TBL] [Abstract][Full Text] [Related]
45. Mycobacteria target DC-SIGN to suppress dendritic cell function.
Geijtenbeek TB; Van Vliet SJ; Koppel EA; Sanchez-Hernandez M; Vandenbroucke-Grauls CM; Appelmelk B; Van Kooyk Y
J Exp Med; 2003 Jan; 197(1):7-17. PubMed ID: 12515809
[TBL] [Abstract][Full Text] [Related]
46. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways.
Lin YL; Liang YC; Lee SS; Chiang BL
J Leukoc Biol; 2005 Aug; 78(2):533-43. PubMed ID: 15894585
[TBL] [Abstract][Full Text] [Related]
47. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
48. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
[TBL] [Abstract][Full Text] [Related]
49. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.
Demangel C; Bean AG; Martin E; Feng CG; Kamath AT; Britton WJ
Eur J Immunol; 1999 Jun; 29(6):1972-9. PubMed ID: 10382760
[TBL] [Abstract][Full Text] [Related]
50. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation.
Hoshino K; Kaisho T; Iwabe T; Takeuchi O; Akira S
Int Immunol; 2002 Oct; 14(10):1225-31. PubMed ID: 12356687
[TBL] [Abstract][Full Text] [Related]
51. Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation.
Godaly G; Young DB
Cell Microbiol; 2005 Apr; 7(4):591-601. PubMed ID: 15760459
[TBL] [Abstract][Full Text] [Related]
52. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
[TBL] [Abstract][Full Text] [Related]
53. Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteria.
Tsunetsugu-Yokota Y; Tamura H; Tachibana M; Ogata K; Honda M; Takemori T
J Leukoc Biol; 2002 Jul; 72(1):115-24. PubMed ID: 12101270
[TBL] [Abstract][Full Text] [Related]
54. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
55. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
Underhill DM; Ozinsky A; Smith KD; Aderem A
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14459-63. PubMed ID: 10588727
[TBL] [Abstract][Full Text] [Related]
56. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton.
Matsumoto M; Seya T; Kikkawa S; Tsuji S; Shida K; Nomura M; Kurita-Taniguchi M; Ohigashi H; Yokouchi H; Takami K; Hayashi A; Azuma I; Masaoka T; Kodama K; Toyoshima K; Higashiyama M
Int Immunopharmacol; 2001 Aug; 1(8):1559-69. PubMed ID: 11515819
[TBL] [Abstract][Full Text] [Related]
57. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering.
Edwards AD; Manickasingham SP; Spörri R; Diebold SS; Schulz O; Sher A; Kaisho T; Akira S; Reis e Sousa C
J Immunol; 2002 Oct; 169(7):3652-60. PubMed ID: 12244157
[TBL] [Abstract][Full Text] [Related]
58. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
59. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
60. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.
Henneke P; Takeuchi O; van Strijp JA; Guttormsen HK; Smith JA; Schromm AB; Espevik TA; Akira S; Nizet V; Kasper DL; Golenbock DT
J Immunol; 2001 Dec; 167(12):7069-76. PubMed ID: 11739528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
